In individuals with pulmonary fibrosis, an infection with Pneumocystis pneumonia can lead to exacerbation of pulmonary fibrosis or further loss of lung function?
Hello Doctor: My grandmother was diagnosed with severe pulmonary fibrosis earlier this year, and in mid-August, she was admitted to the intensive care unit for intubation due to Pneumocystis pneumonia.
She has been receiving treatment for 8 days, using 55% oxygen from the machine, with blood oxygen levels around 88-93.
The doctor mentioned that there has been little progress and stated that if she cannot be weaned off the ventilator and requires a tracheostomy, she may need to go to a nursing home for ventilator care and will have to remain bedridden.
However, my grandmother only has pulmonary fibrosis and myocardial hypoxia (which has been well-managed for several years), and she was able to move around freely without any other health issues.
Since this information was relayed by family members, I cannot directly consult our attending physician.
I have only found limited information online regarding successful weaning off the ventilator after tracheostomy, so I do not fully understand why a tracheostomy would lead to being bedridden if she cannot be weaned off the ventilator.
I would like to ask: 1.
Does infection with Pneumocystis pneumonia in a person with pulmonary fibrosis lead to exacerbation of the fibrosis or loss of lung function? Or can her lung condition return to what it was before the pneumonia after it is treated? She was able to breathe independently before the pneumonia, only experiencing occasional shortness of breath.
2.
If pulmonary fibrosis is severe, could she be classified as a "terminal patient" and receive palliative care? 3.
Can patients who undergo tracheostomy and cannot breathe independently move freely? Or will they necessarily be confined to the bed with the tracheostomy tube secured? Is it possible for them to move within the range of the tubing? Thank you, Doctor, for your kind responses.
Shen Xiaojie, 30~39 year old female. Ask Date: 2019/08/28
Dr. Jian Shuntian reply Pulmonology
Hello:
1.
After an infection, lung function may deteriorate or be lost, with the possibility of partial recovery.
If there is lung damage, it cannot return to completely normal levels, and observation is required for at least three months.
Currently, due to the deterioration of lung function, the use of a ventilator is necessary.
There is a possibility that lung function may gradually improve, allowing for weaning off the ventilator and resuming independent breathing.
2.
If lung function does not improve enough to allow for ventilator weaning within six months, but the patient is not deteriorating to the point of expected death within a foreseeable timeframe, they would not qualify for hospice care.
If the ventilator fails to alleviate the patient's shortness of breath and discomfort, and death is deemed inevitable, the patient may be considered terminal and eligible for palliative care.
However, in Taiwan, most hospice facilities do not accept patients on ventilators.
3.
The use of a ventilator does not necessarily require the patient to be bedridden; it depends on the function of other organs and the type of ventilator used.
If a simple ventilator is sufficient, there may be opportunities for the patient to be active or temporarily wean off the ventilator, but this requires significant manpower, which general hospitals or respiratory wards may not be able to provide.
If feasible, home care could be considered, but it requires at least one experienced caregiver.
4.
Given the variety of circumstances, please discuss in detail with your attending physician, respiratory therapist, or case manager to make the most appropriate choice based on the patient's condition.
Sincerely,
Chest Hospital
Reply Date: 2019/08/28
More Info
Pneumocystis pneumonia (PCP) is a serious opportunistic infection that primarily affects individuals with compromised immune systems, such as those with HIV/AIDS or other conditions that lead to immunosuppression. In patients with pre-existing lung conditions, such as pulmonary fibrosis, the impact of PCP can be particularly severe and multifaceted.
1. Impact on Lung Fibrosis and Function: In patients with pulmonary fibrosis, the lung tissue is already scarred and stiff, which can significantly impair respiratory function. When such patients develop PCP, the infection can exacerbate the existing lung damage. The inflammation and fluid accumulation associated with PCP can lead to further deterioration of lung function. While some patients may recover from the pneumonia, the underlying fibrosis may not improve, and in some cases, it may worsen due to the additional lung injury caused by the infection. Therefore, even if the pneumonia is treated successfully, the patient may not return to their previous level of lung function, particularly if the fibrosis is advanced.
2. Prognosis and End-of-Life Considerations: If a patient with severe pulmonary fibrosis develops PCP and does not respond to treatment, they may be considered for palliative care or hospice services, especially if their prognosis is poor. The determination of being an "end-stage" patient often depends on multiple factors, including the extent of lung damage, overall health status, and the presence of other comorbidities. If the patient's quality of life is significantly compromised and they are not expected to recover, discussions about end-of-life care may become necessary.
3. Tracheostomy and Mobility: A tracheostomy is a surgical procedure that creates an opening in the neck to place a tube directly into the windpipe, allowing for easier breathing. Patients who require a tracheostomy may still have some degree of mobility, depending on their overall condition and the specific setup of their care. While it is common for patients with a tracheostomy to be closely monitored and sometimes restricted in movement to prevent dislodging the tube, many can still engage in limited activities. The ability to move around will depend on the patient's strength, the stability of their respiratory status, and the care protocols in place. In some cases, patients can be mobile within the confines of their medical equipment, but this often requires careful management by healthcare providers.
In summary, the presence of pneumocystis pneumonia in a patient with pulmonary fibrosis can lead to further lung function decline and complicate their overall health status. Recovery from the pneumonia may not restore the patient to their previous baseline if significant lung damage has occurred. Discussions regarding end-of-life care may arise if the patient's condition does not improve. Finally, while a tracheostomy can facilitate breathing, it does not necessarily preclude mobility, although it may limit it depending on the patient's overall health and care environment. It is essential for families to have open discussions with healthcare providers to understand the patient's condition and make informed decisions regarding care and treatment options.
Similar Q&A
Facing My Fears: Understanding Pneumocystis Pneumonia Risks
Dear Dr. Hsu, I apologize for bothering you again. I truly regret what happened ten days ago, so I went to the Veterans General Hospital yesterday for an RT-PCR test. I'm feeling really anxious right now. Additionally, I've noticed that I've been experiencing sympt...
Dr. Xu Weikai reply Urology
Hello, I think things may not be as bad as you think. The doctors at the Veterans General Hospital are very experienced. Let's wait for the report to come out and confirm the results before we think about a course of action. It’s possible that there may be nothing wrong. Sin...[Read More] Facing My Fears: Understanding Pneumocystis Pneumonia Risks
Managing Lung Fibrosis After Bone Marrow Transplant: Key Considerations
The patient is a male in his 30s who was diagnosed with leukemia last year. After chemotherapy, he fortunately found a matched bone marrow donor among his siblings and underwent a transplant. Despite taking immunosuppressive medications, he has experienced multiple episodes of re...
Dr. Yang Wenda reply Pulmonology
Hello, Xiao Zhen: Rejection causes pulmonary inflammation, which ultimately leads to fibrosis, leaving behind sequelae of impaired lung function. Only by using immunosuppressive medications or corticosteroids to reduce the inflammatory response can further deterioration of fibros...[Read More] Managing Lung Fibrosis After Bone Marrow Transplant: Key Considerations
Impact of Alcohol and Smoking on Lung Fibrosis: Exercise Guidelines
I apologize for the inconvenience. May I ask another question? My doctor advised me not to drink alcohol or smoke. What effects would exposure to these substances have on a patient with pulmonary fibrosis and calcification? Also, what constitutes vigorous exercise? Is it acceptab...
Dr. Zhang Zhengda reply Pulmonology
Mr. Mosquito: Q: What is the impact of drinking alcohol and smoking on patients with pulmonary fibrosis and calcification? A: There is generally no direct impact. Q: Is it acceptable to engage in light exercise, such as jogging or practicing basketball, since my doctor advised ag...[Read More] Impact of Alcohol and Smoking on Lung Fibrosis: Exercise Guidelines
Understanding Left Lower Lobe Pulmonary Fibrosis: Causes, Effects, and Treatment
Left lower lobe fibrosis refers to the formation of scar tissue in the lower lobe of the left lung. This condition can lead to a reduction in lung function, causing symptoms such as shortness of breath, chronic cough, and decreased exercise tolerance. The severity of the impact d...
Dr. Jian Shuntian reply Pulmonology
Fibrosis in the right lower lung may be a result of previous inflammation, such as pneumonia or other inflammatory responses. It is typically a benign reaction. To determine if it has any significant impact, further examination is necessary. Please consult a pulmonologist for fur...[Read More] Understanding Left Lower Lobe Pulmonary Fibrosis: Causes, Effects, and Treatment
Related FAQ
(Pulmonology)
Pneumonia(Pulmonology)
Pneumothorax(Pulmonology)
Aspiration Pneumonia(Pulmonology)
Pulmonary Function(Internal Medicine)
Respiratory Distress Syndrome(Pulmonology)
Fibrous Calcification(Pulmonology)
Bronchiectasis(Pulmonology)
Mycobacterium Tuberculosis(Pulmonology)
Chronic Cough(Pulmonology)